What is Zacks Research's Forecast for CL FY2025 Earnings?

Key Points

• Analysts at Zacks Research have raised their FY2025 earnings per share estimate for Colgate-Palmolive from $3.65 to $3.68, with a consensus estimate for the current year set at $3.75 per share.
• Recent earnings results revealed a quarterly EPS of $0.92, surpassing the expected $0.89 EPS, alongside a quarterly revenue of $5.11 billion, above the estimated $5.03 billion.
• Colgate-Palmolive's stock is currently rated as "Hold" by analysts, with an average price target of $98.92, while the company has declared a quarterly dividend of $0.52, yielding 2.4% annually.

Colgate-Palmolive Company (NYSE:CL - Free Report) - Zacks Research upped their FY2025 earnings per share (EPS) estimates for shares of Colgate-Palmolive in a report released on Thursday, August 14th. Zacks Research analyst R. Lohia now anticipates that the company will post earnings per share of $3.68 for the year, up from their previous forecast of $3.65. The consensus estimate for Colgate-Palmolive's current full-year earnings is $3.75 per share. Zacks Research also issued estimates for Colgate-Palmolive's Q1 2026 earnings at $0.97 EPS, Q2 2026 earnings at $0.98 EPS, Q3 2026 earnings at $0.98 EPS, Q4 2026 earnings at $1.00 EPS, FY2026 earnings at $3.93 EPS, Q1 2027 earnings at $1.02 EPS, Q2 2027 earnings at $1.03 EPS and FY2027 earnings at $4.18 EPS.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter last year, the company earned $0.91 EPS. The firm's revenue was up 1.0% compared to the same quarter last year.

Several other analysts have also recently weighed in on the company. Wells Fargo & Company lowered their price target on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a report on Monday, August 4th. Morgan Stanley lowered their price target on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Wall Street Zen cut Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. Citigroup lowered their price target on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a report on Monday, August 4th. Finally, JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Colgate-Palmolive currently has an average rating of "Moderate Buy" and a consensus target price of $98.92.

Colgate-Palmolive Price Performance

Shares of NYSE:CL traded up $1.4590 on Monday, hitting $85.7190. The company's stock had a trading volume of 4,548,147 shares, compared to its average volume of 4,839,570. The company has a 50-day simple moving average of $87.95 and a 200 day simple moving average of $89.95. Colgate-Palmolive has a 1 year low of $82.40 and a 1 year high of $109.30. The company has a market capitalization of $69.28 billion, a PE ratio of 24.08, a PEG ratio of 4.38 and a beta of 0.35. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.4%. The ex-dividend date was Friday, July 18th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.43%.

Hedge Funds Weigh In On Colgate-Palmolive

Institutional investors and hedge funds have recently bought and sold shares of the stock. Westend Capital Management LLC grew its position in shares of Colgate-Palmolive by 111.1% in the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after buying an additional 140 shares during the last quarter. Westside Investment Management Inc. grew its position in shares of Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company's stock worth $26,000 after buying an additional 130 shares during the last quarter. Cornerstone Planning Group LLC grew its position in shares of Colgate-Palmolive by 1,913.3% in the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock worth $28,000 after buying an additional 287 shares during the last quarter. Saudi Central Bank bought a new stake in shares of Colgate-Palmolive in the 1st quarter worth approximately $29,000. Finally, Vermillion & White Wealth Management Group LLC grew its position in shares of Colgate-Palmolive by 86.1% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company's stock worth $30,000 after buying an additional 155 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.